Tuesday in Philadelphia, at the World Drug Safety Congress 2019 (April 16-17), Asymmetrex introduces its AlphaSTEM Test™ to the international pharmaceutical community. By early detection of drug candidates that are stem cell-toxic, Asymmetrex can eliminate drugs that will fail late after great cost because they induce chronic organ failure. By assaying for toxic effects on organ and tissue stem cells specifically, very bad drugs can be identified sooner, without injuring patients, and at greatly reduced development cost. Spend 2 minutes learning more about the technology that Asymmetrex is introducing. #WeCountStemCells…Specifically!
AsymmetrexAsymmetrex Visits World Drug Safety Congress 2019
The information provided by Asymmetrex (“we”, “us”, or “our”) on the Stem Cell Counting Center
Portal [https://asymmetrex.com/stem-cell-counting-center/] (the “Portal”) however accessed,
by internet browser or mobile application, is for general informational purposes only.
All information on the Portal is provided in good faith, however we make no representation or
warranty of any kind, express or implied, regarding the accuracy, adequacy, validity,
reliability, availability or completeness of any information provided to you by the Portal.
In specific, the Portal cannot and does not contain medical or health advice, or treatment
recommendations. The information is provided for general informational and educational purposes
only and is not a substitute for the advice of a qualified medical professional. Accordingly,
before taking any actions based upon information from the Portal, such as formulating dosage
levels and/or treatment plans, we encourage you to consult with a qualified medical professional
and/or specialist. UNDER NO CIRCUMSTANCE SHALL WE HAVE ANY LIABILITY TO YOU FOR ANY LOSS OR DAMAGE
OF ANY KIND INCURRED AS A RESULT OF THE USE OF THE PORTAL, OR RELAINCE ON ANY INFORMATION PROVIDED
BY THE PORTAL. YOU AGREE AND ARE AWARE YOUR USE OR RELIANCE OF ANY PORTAL INFORMATION IS SOLELY AT
YOUR OWN RISK.
Leave a Reply